We also recently demonstrated that stiff and aligned collagen and fibronectin rich matrices deposited by MAFs protected melanoma cells from BRAF/MEK inhibitor treatment, when melanoma cells were cultured on top of these matrices (127). The gene discussed is MAP2K7; the disease is melanoma.